Athena_Telemedicine_Paretnership_LLC

Home>Tag:Athena_Telemedicine_Paretnership_LLC
May 28 2025

Halberd, Athena GTX, Inc. & Athena Telemedicine Partnership, LLC Clinical Study Updates

By |2025-05-27T21:22:22-04:00May 28th, 2025|Investor News, News, Press Releases|0 Comments

Issues nationwide nephrologist solicitation for patients for a 100-patient study involving kidney disease. Jackson Center, PA, May 28, 2025 – Halberd Corporation (OTC "HALB”) in cooperation with Athena Telemedicine Partners, LLC, announces astounding clinical efficacy for our patent-pending LDX compound for dialysis-borne neuropathy and pruritis in yet another case report and issues nationwide nephrologist solicitation ...

Read More
Mar 17 2025

Progress Update on Halberd, Athena GTX and Athena Telemedicine Partnership, LLC Joint Projects

By |2025-03-16T21:52:55-04:00March 17th, 2025|Investor News, News, Press Releases|0 Comments

The US Government Granted Athena GTX a $2,866,000 Final Development Contract Award! Jackson Center, PA, March 17, 2025 – Halberd Corporation (OTC "HALB”) partnered with Athena GTX on a profit-sharing agreement over a year ago.  This enabled Halberd to utilize Athena’s expertise and experience in dealing with the federal government. Of the two technologies associated ...

Read More
INVESTOR/MEDIA INQUIRIES

MEDICAL METAVERSE

As part of our efforts to remain at the forefront of breakthrough technologies in the medical and scientific fields, Halberd Corporation is engaged in scientific study and research in the fields of medicine, the prevention, treatment and management of illness and infections and rapid tests to identify infection, and other medical maladies.

To learn more about how we can further your efforts, or to partner with Halberd on specific healthcare solutions, please email: info@halberdcorporation.com

Go to Top